Arcadia Biosciences
RKDA • NASDAQ
Arcadia Biosciences is a agricultural inputs company in the basic materials sector trading on NASDAQ, led by CEO Thomas J. Schaefer, with a market cap of $2.5M.
CEOThomas J. Schaefer
Next Earnings
Upcoming earnings announcement for Arcadia Biosciences
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.80
Revenue Estimate
$1.6M
Earnings History
Past 12 earnings reports for Arcadia Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.97Est: -$0.66 | -47.0% | $901.0KEst: $1.4M | -35.6% |  10-K |
| Nov 7, 2025 | Q3 2025 | $0.63Est: -$0.54 | +216.7% | $1.3MEst: $1.9M | -31.5% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$3.26 | — | $1.5MEst: $1.6M | -9.1% | 10-Q |
| May 8, 2025 | Q1 2025 | $1.90Est: -$0.37 | +613.5% | $1.2MEst: $1.4M | -14.3% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$2.98Est: -$0.89 | -234.8% | $1.2MEst: $1.2M | +5.7% | 10-K/A |
| Nov 12, 2024 | Q3 2024 | -$1.18Est: -$0.81 | -45.7% | $1.5MEst: $1.4M | +9.8% | 10-Q |
| Aug 13, 2024 | Q2 2024 | $0.78Est: $1.55 | -49.7% | $1.3MEst: $920.0K | +42.0% | 10-Q |
| May 9, 2024 | Q1 2024 | -$1.78Est: -$2.21 | +19.5% | $1.3MEst: $1.2M | +5.5% | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$2.10Est: -$2.58 | +18.6% | $1.2MEst: $1.8M | -33.1% | 10-K/A |
| Nov 9, 2023 | Q3 2023 | -$1.89Est: -$3.19 | +40.8% | $1.6MEst: $1.6M | +3.0% | — |
| Aug 10, 2023 | Q2 2023 | -$2.64Est: -$4.80 | +45.0% | $1.4MEst: $1.8M | -23.7% | — |
| May 11, 2023 | Q1 2023 | -$10.86Est: -$6.85 | -58.5% | $1.5MEst: $1.4M | +7.8% | — |